Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MARK4 Antikörper (C-Term)

MARK4 Reaktivität: Human WB Wirt: Ziege Polyclonal unconjugated
Produktnummer ABIN374191
  • Target Alle MARK4 Antikörper anzeigen
    MARK4 (MAP/microtubule Affinity-Regulating Kinase 4 (MARK4))
    Bindungsspezifität
    • 16
    • 15
    • 13
    • 8
    • 8
    • 6
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reaktivität
    • 49
    • 39
    • 3
    Human
    Wirt
    • 61
    • 1
    • 1
    Ziege
    Klonalität
    • 62
    • 1
    Polyklonal
    Konjugat
    • 24
    • 6
    • 6
    • 6
    • 5
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser MARK4 Antikörper ist unkonjugiert
    Applikation
    • 49
    • 42
    • 13
    • 13
    • 11
    • 7
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Sequenz
    IKRKPPPGCS DSPGV
    Spezifität
    This antibody detects MARK4 at C-term.
    Aufreinigung
    Ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide
    Immunogen
    Peptide from the C Terminus of the protein sequence according to NP_113605.2. Genename: MARK4
    Top Product
    Discover our top product MARK4 Primärantikörper
  • Applikationshinweise
    Peptide ELISA: Limit dilution 1: 128000. Western blot: 0.3-1 μg/mL. Approx 70 kDa band observed in human prostate lysates(calculated MW of 75.0 kDa according to NP_113605.2).
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    0.5 mg/mL
    Buffer
    Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C.
  • Target
    MARK4 (MAP/microtubule Affinity-Regulating Kinase 4 (MARK4))
    Andere Bezeichnung
    MARK4 (MARK4 Produkte)
    Synonyme
    MARK4 antikoerper, MARK4L antikoerper, MARK4S antikoerper, MARKL1 antikoerper, MARKL1L antikoerper, PAR-1D antikoerper, 2410090P21Rik antikoerper, C79806 antikoerper, Markl1 antikoerper, microtubule affinity regulating kinase 4 antikoerper, MAP/microtubule affinity regulating kinase 4 antikoerper, MARK4 antikoerper, Mark4 antikoerper
    Hintergrund
    MARK4 contains an N terminal serine/threonine kinase domain, a central ubiquitin associated domain, and a C terminal KA1 associated kinase domain. RT PCR analysis detects upregulated expression of the gene for MARK4 in nearly all clinical hepatocellular carcinoma cells. Northern blot analysis reveals ubiquitous expression of a 3.6kb transcript, with highest expression in testis. Immunofluorescence microscopy demonstrates homogeneous cytoplasmic expression. Colony forming assays show that MARK4 antisense reduces the growth of SNU475 cells. It has been suggested that MARK4 provides a growth advantage to cells.Synonyms: MAP microtubule affinity-regulating kinase 4, MARKL1
    Gen-ID
    57787
    NCBI Accession
    NP_113605
    UniProt
    Q96L34
Sie sind hier:
Kundenservice